Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06430892

RAPID-POP a Randomized Controlled Trial

Led by National Institute of Cardiovascular Diseases, Pakistan · Updated on 2024-05-29

400

Participants Needed

1

Research Sites

24 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Efficacy of the Pressure Optimization Protocol (POP) versus Conventional Stent Deployment Strategy during Primary PCI: An Open Label Randomized Clinical Trial The investigators will compare conventional rapid stent inflation/deflation during primary PCI with higher pressure and prolonged duration of stent deployment Study Hypothesis: The POP in stent deployment is superior to the conventional stent deployment approach with a significantly higher achievement of the TIMI III flow, significantly lesser occurrence of slow flow/no-reflow, and significantly higher rate of ST-Segment resolution during primary PCI.

CONDITIONS

Official Title

RAPID-POP a Randomized Controlled Trial

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients aged 18 years and above.
  • Patients undergoing primary percutaneous coronary intervention (PCI) with stent implantation.
  • Presence of significant coronary artery stenosis (greater than 70% diameter reduction) confirmed by angiography.
Not Eligible

You will not qualify if you...

  • Patients with Killip class IV.
  • Patients with significant comorbidities such as end-stage renal disease or advanced liver disease which may interfere with the procedure or follow-up.
  • Prior history of coronary artery bypass grafting (CABG).
  • Refusal to give consent for study participation or procedure.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

National institute of cardiovascular diseases

Karachi, Sindh, Pakistan, 75510

Actively Recruiting

Loading map...

Research Team

A

Abdul Hakeem, professor

CONTACT

S

Shakir Zada, fellow

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here